
Cytiva HyClone

Cytiva HyClone
The origin of HyClone™ Laboratories is indeed a plot twist! It began in 1967 when Dr. Rex Spendlove, who was then a professor at Utah State University, was studying a viral disease that is deadly to children. His research is inseparable from fetal bovine serum (FBS). The quality of fetal cattle serum was so poor that Dr. Spendlove had to develop some methods to produce high-quality serum by himself. Finally, HyClone™ was obtained, thus creating a variety of serum collection, filtration and processing technologies used by manufacturers of cell culture products.
Cytiva is a global technology and service provider committed to promoting unseen technologies and accelerating extraordinary therapies. The company's long history goes back hundreds of years ago. In 2020, it became an independently operated company under the Danaher Group, and has embarked on a new journey.
From basic biological research to the research and development of innovative vaccines, from biomedicine to the development of new cell and gene therapies, the work of the company’s customers is closely related to life. The company's products and services provide strong support to customers, helping them accelerate research, reduce costs and increase efficiency, thereby benefiting patients around the world.